Insider Purchases: Inside the Buy
Tag: insider buying
Moderna: Messenger RNA Medicines Powerhouse Sends A New Message — “Discount!”
Insiders dropped $6M on Moderna stock. With a massive mRNA pipeline and deep-pocketed backers, is this biotech beast ready to roar again?
Oscar Health: Its Own Is Shining and Insiders Knew!
Co-founder Joshua Kushner and Thrive Partners bought over $23 million of Oscar Health stock in late 2024. Since then? Record earnings, soaring revenue, and a stock still (surprisingly) within range. A healthy bet — or just a well-insured hunch?
CEO Bought Shares: Is Full House Worth Betting the House?
Full House Resorts is growing fast—but still bleeding cash. The CEO’s massive insider buy may hint at a turnaround, but with debt looming and expansion plans on the table, is FLL worth a gamble? We break it down—odds, icons, and all.
Can Robinhood Still Steal the Show?
Robinhood’s got a new backer — and it’s no amateur. Christopher Payne (ex-DoorDash, Tinder, eBay) just went all in with a bold $2M+ insider buy. Add in huge crypto growth, a string of acquisitions, and global ambitions… and suddenly Robinhood doesn’t just look ready — it looks legendary. Is $HOOD still a buy? Let’s break it down.
Vera Bradley: The Bags Are Pretty; the Financials? Not So Much
The bags? Still adorable. The stock? Still near record lows. With insiders finally buying and a CEO exit underway, is Vera Bradley set for a stylish rebound — or is it still stuck in the clearance bin?
Magnera: Insiders Keep Buying… Should You?
Magnera’s boardroom is buying diapers—literally. With insiders piling in and free cash flow returning, this specialty materials firm might be worth more than just its wipes. But don’t forget the debt and diaper jokes.
Can Lyft Ever Lift Off or Will It Forever Uber-Underwhelm?
CEO David Risher has been scooping up Lyft shares like surge-priced burritos—and with record rides, rising cash flow, and a $750M buyback plan, the bullish case is stronger than ever. But can LYFT finally fly—or is Uber still driving the narrative?
Can Sweetgreen’s Stock Get Any Less Bitter?
Sweetgreen just served up its first insider buy since IPO—should investors take a bite? The fast-casual salad giant keeps growing but hasn’t turned a profit. We chop into the numbers, spice it up with fun, and toss in all the risks. 🥗📉
Xerox Holdings: This Company Still Exists—To Be or Not To Be... In Your Portfolio?
Xerox might feel like yesterday’s news, but insiders and institutions clearly disagree. With executives loading up on shares and a reinvention strategy underway, this classic name could be more than a relic—it might just be your next contrarian play. 📠💥
Can V.F. Corporation Face North and Land More Than Timber?
Insiders are buying, the CEO’s betting big, and the stitches are finally tightening at V.F. Corp. With a turnaround in motion and brands like Vans and Timberland in the mix, could this stock step back into fashion?